Navigation Links
Berkery Noyes Releases First Half 2011 M&A Report for the Pharma and Healthcare Information and Technology Industry
Date:7/20/2011

NEW YORK, July 20, 2011 /PRNewswire/ -- Berkery Noyes, the leading independent investment bank specializing in the information content and technology industries, today released its Half Year Mergers and Acquisitions Trends Report for the Pharma and Healthcare Information and Technology Industry.

The report analyzes merger and acquisition activity in the Pharma and Healthcare Information and Technology market over the first half of 2011 and compares it with activity in the four previous sixth-month periods. This market includes information and technology companies servicing pharma, healthcare payor and healthcare provider spaces.

Berkery Noyes data shows that while deal volume increased by seven percent to 143 transactions announced this half year, total aggregate deal value fell 28 percent to $3.4 billion from $4.8 billion in 2nd Half 2010.  Despite this, both median deal value and median EBITDA multiples rose over the same time period.

"The data confirms what we are seeing in our deal flow," said Tom O'Connor, managing director at Berkery Noyes. "Strategic buyers, including those with private equity backing, are looking to acquire smaller, fast growing companies with unique solutions in their current or related markets. We expected M&A activity in Pharma and Healthcare Information and Technology sectors to be robust for the next 18 to 24 months."

Reed Elsevier and LLR Partners both announced three transactions this half year, tying as the most acquisitive companies in the Pharma and Healthcare space.  Reed Elsevier purchased an e-clinical reference solution and two medical media companies, while LLR Partners focused their three purchases on medical record management.  

For the full two-and-a-half period covered by the report, UnitedHealth Group was the most active acquirer covered in this report, making nine transactions: A-Life Medical, Inc., Axolotl Corporation, Executive Health Resources, Inc., Picis, Inc., ChinaGate, QualityMetric, Inc., Scriptswitch Limited, CareMedic Systems, Inc. and AIM Healthcare Services, Inc.

Unique among investment banking firms, Berkery Noyes combines independent strategic research and industry intelligence with senior information technology banking expertise. Long having been an innovator in database and research technology in M&A, Berkery Noyes has committed itself to providing more expansive and more current information on the acquisition activity in their respective sectors.

A copy of the First Half 2011 Pharma and Healthcare Information and Technology Industry M&A Report is available at the Berkery Noyes website.

About Berkery Noyes

Berkery Noyes is an independent investment banking advisory firm servicing the information industry. Focused on middle-market corporations and financial sponsors, Berkery Noyes is committed to delivering a comprehensive array of industry-leading advisory services. Since its founding by Joseph W. Berkery in 1983, the firm has worked with corporate clients to grow through acquisition, divest non-core assets, and maximize shareholder returns through strategic transactions and restructurings. For private owners, Berkery Noyes helps create liquidity and execute timely exit strategies that achieve the personal and professional objectives. For more information, visit www.berkerynoyes.com.


'/>"/>
SOURCE Berkery Noyes
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Berkery Noyes Represented The Thomson Corporation in the Sale of CenterWatch and New England Institutional Review Board to Jobson Medical Information
2. Berkery Noyes Releases 2009 Pharma and Healthcare Information Merger & Acquisition Trends
3. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
4. CEL-SCI Corporation Releases Letter to Shareholders
5. AcroMetrix Releases New OptiQuant(R) HIV-1 Quantification Panel
6. Cardinal Health Releases New Tool to Combat MRSA Infections in Hospitals
7. Immunosyn Corporation Releases SF-1019 Study Results
8. TCS Healthcare Technologies Releases Three New Clinical Care Programs Within ACUITY
9. Immunosyn Releases Wound Healing Photographs From the First Phase Proof of Concept Trial in Europe for Treatment of Diabetic Ulcers With Biopharmeceutical SF-1019
10. QRxPharma Releases Successful Phase 3 Study Results for Dual Opioid Pain Therapy
11. CenterWatch Releases State of the Clinical Trials Industry 2008 - A Key Industry Resource for Market Research and Competitive Intelligence
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... 2017   Pulmatrix, Inc . (NASDAQ: PULM), a clinical ... pulmonary diseases, today announced that it has added two experts ... asthma to its Scientific Advisory Board . ... B. Moss , MD, former chief of the Pediatric Pulmonary ... Center at Stanford University, and David ...
(Date:3/27/2017)... FRANCISCO , March 27, 2017 ... expected to reach USD 16.0 billion by 2025, according ... The growing prevalence of chronic diseases is anticipated to ... chemistry analyzers, which thereby widens the scope for growth ... geriatric and bariatric population, which is highly susceptible to ...
(Date:3/27/2017)... BOSTON , March 27, 2017 ... pharmaceutical company and Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), ... commercialization of innovative therapies based upon tetracycline chemistry, ... sarecycline for the treatment of moderate to severe ... Sarecycline is a once-daily, oral, narrow spectrum tetracycline-derived ...
Breaking Medicine Technology:
(Date:3/28/2017)... ... March 28, 2017 , ... ... desire to achieve the “perfect smile.” The National Association of Dental Laboratories (NADL) ... what dentists should be aware of when utilizing dental laboratories and technicians that ...
(Date:3/28/2017)... ... March 28, 2017 , ... The ... in Atlantic City March 13-16, was a busy spot this year. Liz Solovay ... discussed strategies for preventing outbreaks among camp communities during the upcoming 2017 camping ...
(Date:3/28/2017)... ... 28, 2017 , ... Thank you to all who attended Capio Partners Winter ... event was exclusive to providers and offered an opportunity to collaborate and network with ... Manchester Grand Hyatt where attendees gathered for a lively discussion on trends and issues ...
(Date:3/27/2017)... ... March 27, 2017 , ... New patients who have sleep apnea ... treatment, with or without a referral. Sleep apnea is often left untreated because patients ... morning headaches and chronic snoring. , Dr. Braasch seeks to raise awareness of ...
(Date:3/27/2017)... ... 2017 , ... Drs. Justin Kolnick, Kara Diamond, Randall Barton, Keith Hope and ... key role this treatment plays in protecting oral health, along with the benefits of ... who need a root canal in White Plains, NY or their second location in ...
Breaking Medicine News(10 mins):